Device Trial Radar · NCT01638390
Use of the VisuMax™ Femtosecond Laser
Last checked: Nov 20, 2026Latest source record: Apr 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
357
Actual
Start
Jul 2012
Primary completion
Apr 2016
Study completion Apr 2016
Sponsor
- Lead sponsor
- Carl Zeiss Meditec, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 11, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this clinical trial is to evaluate the safety and effectiveness of the Carl Zeiss Meditec VisuMax™ Femtosecond Laser lenticule removal procedure for the reduction or elimination of myopia from ≥ -1.00 D to ≤ -8.00 D with ≤ -0.50 D cylinder and MRSE (Manifest Refractive Spherical Equivalent) ≤ -8.25 D.
Conditions
- Myopia
Interventions
Treatment with the VisuMax™ Femtosecond LaserDevice
The reduction or elimination of myopia from ≥ -1.00 D to ≤ -8.00 D with ≤ -0.50 D cylinder and MRSE ≤ -8.25 D.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Effectiveness- Predictability of Participant Refractive OutcomesTime frame: 12 months
- Effectiveness- Number of Participants With an Improvement in UCVA Following TreatmentTime frame: 12 month
- Stability Criteria- Number of Participants With a Change Between Visits Within 1.00 Diopter (D)Time frame: 6 months
5 more outcomes with a free account
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Dishler Laser Institute
Greenwood Village, Colorado
Bascom Palmer Eye Institute
Miami, Florida
Discover Vision Centers
Leawood, Kansas
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.